Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 145.73M | $ 46.61M | $ 0 | -31.98% |
3/31/2025 | $ 174.18M | $ 17.12M | $ 0 | -9.83% |
12/31/2024 | $ 226.96M | $ 29.28M | $ 0 | -12.9% |
9/30/2024 | $ 565.43M | $ 22.29M | $ 0 | -3.94% |
6/30/2024 | $ 206.14M | $ 22.29M | $ 0 | -10.81% |
3/31/2024 | $ 108.53M | $ 29.45M | $ 0 | -27.14% |
12/31/2023 | $ 140.44M | $ 16.04M | $ 0 | -11.42% |
9/30/2023 | $ 104.81M | $ 35.5M | $ 0 | -33.87% |
6/30/2023 | $ 201.91M | $ 79.45M | $ 0 | -39.35% |
3/31/2023 | $ 218.22M | $ 95.8M | $ 0 | -43.9% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for SANGAMO THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 148.01M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 1.67B ]
(=) Payout Yield [ -8.85% ]
Minimum
Mar 31, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |